Table 2. Open in new tab Individual...

Age at participation, y

Combined oral contraceptive washout, wk

Dopamine agonist, wk

Prolactin at screening, ng/mL

Prolactin at visit 1, ng/mL

Prolactin at visit 2, ng/mL

Progesterone at visit 1, ng/mL

Progesterone at visit 2, ng/mL

1^a

9.7

2.0

19.4

28.4

29.8

2.09

3.15

7.7^b

n/a

61.2

24.6

34.3

0.20

11.3

3^a

n/a

2.1

41.5

51.6

44.5

4.94

0.40

4^a

n/a

2.6

40.5

57.8

54.9

2.92

1.15

5^a

n/a

3.6

21.5

34.9

35.3

6.09

6.58

6^a

n/a

14.7^b^,^c

331.5

150^d

0.25

0.29

n/a

17^b^,^c

37.5

34.1

35.0

0.39

0.45

8^a

10.3

6.6

< 1.0

24.8

24.9

9.19

9.25

n/a

50.6

63.3

61.2

0.44

0.20

10^a

n/a

34.6

77.2

75.9

8.64

6.78

11^a

8.9

n/a

36.9

27.0

28.2

1.00

0.31

Table 2.

Open in new tab

Individual characteristics at participation

ID	Age at participation, y	Combined oral contraceptive washout, wk	Dopamine agonist, wk	Prolactin at screening, ng/mL	Prolactin at visit 1, ng/mL	Prolactin at visit 2, ng/mL	Progesterone at visit 1, ng/mL	Progesterone at visit 2, ng/mL
1^a	40	9.7	2.0	19.4	28.4	29.8	2.09	3.15
2	38	7.7^b	n/a	61.2	24.6	34.3	0.20	11.3
3^a	41	n/a	2.1	41.5	51.6	44.5	4.94	0.40
4^a	44	n/a	2.6	40.5	57.8	54.9	2.92	1.15
5^a	39	n/a	3.6	21.5	34.9	35.3	6.09	6.58
6^a	36	n/a	14.7^b^,^c	331.5	150^d	150^d	0.25	0.29
7	23	n/a	17^b^,^c	37.5	34.1	35.0	0.39	0.45
8^a	24	10.3	6.6	< 1.0	24.8	24.9	9.19	9.25
9	35	n/a	n/a	50.6	63.3	61.2	0.44	0.20
10^a	24	n/a	n/a	34.6	77.2	75.9	8.64	6.78
11^a	30	8.9	n/a	36.9	27.0	28.2	1.00	0.31

ID	Age at participation, y	Combined oral contraceptive washout, wk	Dopamine agonist, wk	Prolactin at screening, ng/mL	Prolactin at visit 1, ng/mL	Prolactin at visit 2, ng/mL	Progesterone at visit 1, ng/mL	Progesterone at visit 2, ng/mL
1^a	40	9.7	2.0	19.4	28.4	29.8	2.09	3.15
2	38	7.7^b	n/a	61.2	24.6	34.3	0.20	11.3
3^a	41	n/a	2.1	41.5	51.6	44.5	4.94	0.40
4^a	44	n/a	2.6	40.5	57.8	54.9	2.92	1.15
5^a	39	n/a	3.6	21.5	34.9	35.3	6.09	6.58
6^a	36	n/a	14.7^b^,^c	331.5	150^d	150^d	0.25	0.29
7	23	n/a	17^b^,^c	37.5	34.1	35.0	0.39	0.45
8^a	24	10.3	6.6	< 1.0	24.8	24.9	9.19	9.25
9	35	n/a	n/a	50.6	63.3	61.2	0.44	0.20
10^a	24	n/a	n/a	34.6	77.2	75.9	8.64	6.78
11^a	30	8.9	n/a	36.9	27.0	28.2	1.00	0.31

Data gathered from documentation in each participant’s study file. Age at participation was calculated using the date of visit 1. Length of washout was calculated by subtracting start date of washout from date of visit 1. Prolactin at visit 1 includes the mean value from all study pools from visit 1. Prolactin at visit 2 includes the mean value from study pools that were collected during kisspeptin administration (hour 1-hour 11).

Abbreviations: ID, identification; n/a, individuals who were not taking these types of medication and therefore did not undergo washout.

^aPulse occurred within 30 minutes of first kisspeptin administration.

^bThe last day of the month was used as the start date of washout as only the month was recorded for start date of washout.

^cParticipants began their washout before screening visit as part of their clinical care.

^dThis sample returned value above the limit of detection (upper range 150 ng/mL was recorded for this individual).

This Feature Is Available To Subscribers Only